Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Using compounding to grow wealth over time can lead to significant financial advantages. Explore how this strategy can benefit your future.
26,433 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Investors are eyeing a potential rebound for Figma as enterprise adoption grows and AI-driven updates sharpen the pla...
One stock that's more than doubled in three years has turned heads in growth-focused portfolios. This article dives i...
Rivian surprised investors with higher-than-expected Q2 deliveries and a raised full-year delivery outlook. This arti...
New housing designs like duplexes and townhomes are rising in policy talks, but recent data show they don’t automatic...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
New consolidation options are rolling out in 2026 as rates hold steady. Borrowers weigh relief from payments against ...
A high-conviction AI bet is reshaping how Ackman runs his hedge fund. Learn why nearly 40% of his capital sits in thr...
Bitcoin slides roughly 3% after hotter-than-expected January PPI data; a surge in services inflation is prompting a f...
A trio of S&P 500 dividend stocks that pay monthly dividends are outperforming the broader index, delivering reliable...
When Paramount beat Netflix in the bid for Warner Bros. Discovery’s assets, headlines screamed victory. This piece di...